PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal
Abstract
Authors
I. Monteiro A. Cafe R. Encarnação A. Diamantopoulos F. Dejonckheere